Helping Iraq’s Ministry of Health battle antimicrobial resistance
ANTIMICROBIAL resistance (AMR) is a growing and silent pandemic that according to the World Health Organisation (WHO) can successfully be addressed through collaborative efforts and multifaceted approaches and so have developed the ‘Antimicrobial Resistance Global Action Plan’ (AMR GAP) to contribute to a worldwide determination in discovering a solution.
Now, an expert in clinical pharmacy from the University of Huddersfield has been supporting the WHO with the global delivery of their Action Plan by hosting virtual workshops for hospital pharmacists and key focal representatives involved in antimicrobial surveillance and stewardship in Iraq.
Dr Mamoom Al Deyab is a Senior Lecturer in Clinical Pharmacy within the University’s School of Applied Sciences. Through the delivery of the workshops, he was able to distribute and explain the essential and technical expert advice issued by the WHO to Iraq’s Ministry of Health and the benefits of documenting antimicrobial usage and consumption at the hospital level, particularly for the highest priority and critically important antimicrobials, as classified by the WHO.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.